Avidity Biosciences Inc (RNA)
24.63
-0.07
(-0.28%)
USD |
NASDAQ |
Apr 30, 11:22
Avidity Biosciences Free Cash Flow: -123.29M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -123.29M |
| September 30, 2023 | -178.97M |
| June 30, 2023 | -173.11M |
| March 31, 2023 | -159.55M |
| December 31, 2022 | -139.09M |
| September 30, 2022 | -126.97M |
| June 30, 2022 | -116.70M |
| March 31, 2022 | -108.68M |
| December 31, 2021 | -98.55M |
| Date | Value |
|---|---|
| September 30, 2021 | -83.94M |
| June 30, 2021 | -72.32M |
| March 31, 2021 | -51.26M |
| December 31, 2020 | -38.21M |
| September 30, 2020 | -30.01M |
| June 30, 2020 | -25.95M |
| March 31, 2020 | -2.809M |
| December 31, 2019 | 2.49M |
Free Cash Flow Range, Past 5 Years
-178.97M
Minimum
Sep 2023
2.49M
Maximum
Dec 2019
-89.82M
Average
-98.55M
Median
Dec 2021
Free Cash Flow Benchmarks
| Ironwood Pharmaceuticals Inc | 183.15M |
| Codexis Inc | -57.06M |
| HOOKIPA Pharma Inc | -61.68M |
| DocGo Inc | -74.35M |
| Kineta Inc | -16.21M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 16.50M |
| Cash from Investing (Quarterly) | 51.04M |
| Cash from Financing (Quarterly) | 31.89M |
| Free Cash Flow Per Share (Quarterly) | 0.2055 |
| Free Cash Flow to Equity (Quarterly) | 15.64M |
| Free Cash Flow Yield | -6.86% |